Rheumatoid arthritis: open trials in Italy

24 open trials have a site in Italy. Registry data; only the trial team decides who can take part.

NCT05717179
Ultrasound to Guide Treatment Decisions in Patients With Rheumatoid Arthritis According to a T2T Approach
Trial Treatment · Italian Society for Rheumatology
Azienda Sanitaria dell'Alto Adige, Bruneck
Registry updated 2026-11-04
NCT07363590
A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)
Trial Treatment · Phase 1 · Merck Sharp & Dohme LLC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-11-02
NCT07412704
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-10-23
NCT02418442
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Research · Duke University
IRCCS Ospedale Pediatrico Bambino Gesu (OPBG), Rome
Registry updated 2026-10-21
NCT06994143
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Rheumatoid Arthritis
Trial Treatment · Phase 1 · Cullinan Therapeutics Inc.
Fondazione Policlinico Universitario A Gemelli, Rome · Humanitas Research Hospital, Rozzano
Registry updated 2026-10-20
NCT07137598
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
Trial Treatment · Phase 2 · Hoffmann-La Roche
Arcispedale S. Maria Nuova Azienda Ospedaliera Di Reggio Emilia, Reggio Emilia · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome · Istituto Clinico Humanitas, Rozzano
Registry updated 2026-10-16
NCT07620392
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
Trial Treatment · Phase 2 · Hoffmann-La Roche
Azienda Ospedaliera di Padova, Padova · Azienda USL IRCCS di Reggio Emilia, Reggio Emilia · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-10-16
NCT07245992
A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis
Trial Treatment · Phase 1 · Philogen S.p.A.
AUSL di Reggio Emilia IRCCS, Arcispedale Santa Maria Nuova di Reggio Emilia, Reggio Emilia · Centro Ricerche Cliniche di Verona s.r.l., Verona
Registry updated 2026-10-14
NCT02748408
The Medacta International SMS Post-Marketing Surveillance Study
Research · Medacta International SA
Istituto Ortopedico Galezzi, Milan
Registry updated 2026-10-13
NCT06570798
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Trial Treatment · Phase 2 · Amgen
IRCCS Ospedale San Raffaele, Milan · IRCCS Istituto Clinico Humanitas, Rozzano · Ospedale San Giovanni Bosco, Turin
Registry updated 2026-10-05
NCT05603728
Exactech Shoulder Post Market Clinical Follow-up Study
Research · Exactech
Policlinico Morgagni, Catania · Campolongo Hospital, Eboli
Registry updated 2026-09-17
2025-521034-28-00
A Study to Assess the Efficacy and Safety of RO7790121 in Patients with Moderate to Severe Rheumatoid Arthritis who have not Responded to or who Cannot Tolerate TNF and/or JAK Inhibitors
Trial Treatment · Phase 2 · F. Hoffmann-La Roche AG
Azienda Ospedaliera di Padova, Padova · Azienda USL IRCCS di Reggio Emilia, Reggio Emilia · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-09-14
2024-511470-79-00
3TR-PARTNER-RA
Trial Treatment · Phase 4 · Queen Mary University Of London
Azienda Ospedaliero-Universitaria Di Cagliari, Monserrato · Azienda Ospedaliero Universitaria Maggiore della Carità, Novara · Azienda Ospedaliera di Padova, Padova · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-09-09
2025-523127-21-00
A Study to Evaluate Targeted Therapies for Patients with Rheumatoid Arthritis
Trial Treatment · Phase 1 · AbbVie Deutschland GmbH & Co. KG
University Hospital Of Ferrara, Ferrara · Fondazione IRCCS Policlinico San Matteo, Pavia · Azienda USL IRCCS di Reggio Emilia, Reggio Emilia · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-09-01
2022-502021-18-00
The 3TR Molecular Pathobiology-Driven Precision Therapy in RA (3TR Precis-The-RA) study
Trial Treatment · Phase 4 · Queen Mary University Of London
ASST Grande Ospedale Metropolitano Niguarda, Milan · Azienda Ospedaliera Universitaria Di Cagliari, Monserrato · Azienda Ospedaliera di Padova, Padova · Azienda Ospedaliero-Universitaria Policlinico Umberto I, Rome · Humanitas Research Hospital, Rozzano · A.O.U Maggiore della Carità
Registry updated 2026-08-05
NCT06991114
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Trial Treatment · Phase 2 · Artiva Biotherapeutics, Inc.
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia, Brescia · Ospedale San Raffaele S.r.l., Milan · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome
Registry updated 2026-07-31
NCT02469662
Clinical Outcomes Study of the Nexel Total Elbow
Trial Treatment · Zimmer Biomet
AO Mauriziano, Torino
Registry updated 2026-07-09
NCT07680101
Intra-Articular Adelmidrol 2%/Hyaluronic Acid 1% With or Without m/umPEA, in Knee Pain Due to Joint Degeneration.
Trial Treatment · Universita di Verona
Azienda Ospedaliera Universitaria Integrata Verona, Verona
Registry updated 2026-07-02
NCT07371468
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Trial Treatment · Phase 1 · GlaxoSmithKline
University Hospital Of Ferrara, Ferrara · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-06-23
NCT07571993
Rheumatoid Arthritis Remission Screening and Prospective Surveillance
Research · Fondazione IRCCS Policlinico San Matteo di Pavia
Fondazione IRCCS Policlinico San Matteo, Pavia
Registry updated 2026-05-07
2024-519114-31-00
A Phase I, Open-Label Study of CLN-978 in Patients with Treatment-Refractory Rheumatoid Arthritis (RA)
Trial Treatment · Phase 1 · Cullinan Therapeutics Inc.
Azienda Ospedaliera Universitaria - Universita degli Studi della Campania Luigi Vanvitelli, Naples · Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome · Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-05-06
2023-507714-27-00
MethMax trial
Trial Treatment · Phase 4 · Medical University of Vienna
Humanitas Mirasole S.p.A., Rozzano
Registry updated 2026-02-02
NCT07174102
Radiologic Features of Rheumatoid Arthritis Interstitial Lung Disease at Chest High Resolution Computed Tomography
Research · Azienda Unita Sanitaria Locale di Piacenza
UOC Reumatologia, Arcipedale Sant'Anna, Ferrara · SC Malattie Apparato Respiratorio, Azienda Policlinico di Modena, Modena · Local Health Unit ("Azienda Unità Sanitaria Locale", AUSL) of Piacenza, Piacenza · AUSL IRCCS di Reggio Emilia, Reggio Emilia
Registry updated 2025-09-15
NCT05548972
G7 Dual Mobility With Vivacit-E or Longevity PMCF
Trial Treatment · Zimmer Biomet
Istituto San Siro, Milan
Registry updated 2025-06-15

All Rheumatoid arthritis trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error